Clinical trials in Cholargos – page 2

Comprehensive studies evaluating novel treatments for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including investigations of targeted therapies and immunotherapy combinations.

• Advanced treatment comparisons
• Therapy combinations evaluation
• Metastatic disease management

Research focuses on improving survival rates and treatment effectiveness for patients with various stages of lung cancer.

Innovative clinical trials examining treatments for HER2-positive and estrogen receptor-positive breast cancer, with particular attention to early-stage and metastatic conditions.

• Targeted therapeutic approaches
• Hormone therapy evaluation
• Recurrence prevention

Studies aim to enhance treatment outcomes and reduce recurrence risks in breast cancer patients.

Advanced research into bladder cancer and metastatic prostate cancer, exploring innovative combination therapies and novel treatment approaches.

• Immunotherapy combinations
• Treatment resistance studies
• Novel drug evaluations

Trials focus on improving treatment outcomes for patients with advanced urological malignancies.

Studies investigating treatments for advanced colorectal cancer, particularly focusing on specific genetic mutations and targeted therapies.

• Mutation-specific treatments
• Combination therapy assessment
• Advanced disease management

Research aims to develop personalized treatment approaches based on genetic profiles.